CORPORATE STRUCRURE
CAPITAL AND SHAREHOLDER STRUCTURE
The company accepted the authorized capital system according to code numbered 6362 and transmitted it to the authorized capital system with the permission of the Capital Markets Board of Turkey dated 08 April 2021 and numbered 19/595. Between the years 2021 and 2025, our company’s authorized capital limit is TL 1.250.000.000 and issued capital is TL 300.000.000. TL 55.000.000 portion of the total capital consists of A group shares and the remaining TL 245.000.000 portion consist of B group shares.
In accordance with Article 7 of our company’s Articles of Association, A group of shareholders have the privilege to promote board members. Also, according to Article 10 of our company’s Articles of Association, each A group share has 5(five) voting right in the general assembly.
The company’s capital has been registered and announced on Trade Registry Gazette dated 14 September 2021 and numbered 10408
BOARD OF DIRECTORS
Chairman of the Board
Deputy Chairman of the Board
Deputy Chairman of the Board
Board Member (Independent)
Board Member (Independent)
SENIOR MANAGEMENT
Chairman of the Board
Deputy Chairman of the Board
Deputy Chairman of the Board
Board Member (Independent)
Board Member (Independent)
Vice President (Sales & Marketing)
Vice President (R&D and Manufacturing)
Vice President (Foreign Trade)
Vice President (Strategy & Corporate Development)
ARTICLES OF ASSOCIATION
Company Name: Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.
Register Number: Ankara Trade Registry Directorate – 131040
Articles of Incorporation
